Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL17A [2] IL17A, TNFSF13B 💬
|
Tibulizumab Tibulizumab 💬
| Tibulizumab | 053 [1] 53 💬
|
| 2 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
TNFSF13 [2] TNFSF13, TNFSF13B 💬
|
Atacicept Atacicept 💬
| Atacicept | 013 [4] 13, 46, 49, 66 💬
|
| 3 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Belimumab Belimumab 💬
| Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
|
| 4 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Tabalumab Tabalumab 💬
| Tabalumab | 046 [2] 46, 49 💬
|
| 5 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
TNFSF13 [2] TNFSF13, TNFSF13B 💬
|
Atacicept Atacicept 💬
| Atacicept | 013 [4] 13, 46, 49, 66 💬
|
| 6 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Belimumab Belimumab 💬
| Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
|
| 7 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Tabalumab Tabalumab 💬
| Tabalumab | 046 [2] 46, 49 💬
|
| 8 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Tibulizumab Tibulizumab 💬
| Tibulizumab | 053 [1] 53 💬
|
| 9 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Atacicept Atacicept 💬
| Atacicept | 013 [4] 13, 46, 49, 66 💬
|
| 10 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Belimumab Belimumab 💬
| Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
|
| 11 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Tabalumab Tabalumab 💬
| Tabalumab | 046 [2] 46, 49 💬
|
| 12 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Tibulizumab Tibulizumab 💬
| Tibulizumab | 053 [1] 53 💬
|
| 13 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
IL17A [2] IL17A, TNFSF13B 💬
|
Tibulizumab Tibulizumab 💬
| Tibulizumab | 053 [1] 53 💬
|
| 14 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
TNFSF13 [2] TNFSF13, TNFSF13B 💬
|
Atacicept Atacicept 💬
| Atacicept | 013 [4] 13, 46, 49, 66 💬
|
| 15 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Belimumab Belimumab 💬
| Belimumab | 011 [13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
|
| 16 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
TNFSF13B [1] TNFSF13B 💬
|
Tabalumab Tabalumab 💬
| Tabalumab | 046 [2] 46, 49 💬
|